Selman KESİCİ, Şule ÜNAL, Barış KUŞKONMAZ, Selin AYTAÇ, Mualla ÇETİN, Fatma GÜMRÜK

Fanconi anemia: a single center experience of a large cohort

Fanconi anemia (FA) is an inherited disease, characterized by congenitalmalformations, short stature, progressive bone marrow failure andpredisposition to leukemia and solid tumors. The aim of this study was toevaluate the clinical and prognostic features of FA patients followed in asingle center.The charts of FA patients were reviewed 35 years retrospectively and a total of175 patients were included in the study in which 51.4% of patients were male.The mean age at diagnosis was 6.3±4.1 years. The incidence of microcephalywas 92.6%, skin findings were 88.0%, eye abnormality was 74.3%, thumband radius abnormality was 53.1%, urinary system abnormality was 30.9%,skeletal system abnormality other than thumb and radius was 18.9%, genitalsystem abnormality was 11.4%, cardiovascular system abnormality was11.4%, ear and hearing abnormalities were 9.7% and gastrointestinal systemabnormality was 5.7%. Short stature was present in 75.4% of the patients.Of the 175 patients 167 (95.4%) developed bone marrow failure duringfollow-up and the mean age of bone marrow failure was 7.1 ±3.7 years (1month-old-19.8 years). The first clinical symptom was thrombocytopenia in83.4% of patients. Malignancy developed in a total of 23 (13.1 %) patients(20 leukemia, 3 solid tumors) during follow-up. Of 175 patients, 35 (20%)underwent hematopoietic stem cell transplantation. Fatality rate amongpatients who underwent hematopoietic stem cell transplantation was 31.4%(11/35) and fatality rate among other patients was 63.4% (83/131; p

PDF

___

1. Auerbach AD, Wolman SR. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1976; 261: 494-496.

2. Schroeder TM, Tilgen D, Krüger J, Vogel F. Formal genetics of Fanconi's anemia. Hum Genet 1976; 32: 257-288.

3. Alter BP. Bone marrow failure syndromes. Clin Lab Med 1999; 19: 113-133.

4. Callen E, Casado JA, Tischkowitz MD, et al. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 2005; 105: 1946- 1949.

5. Datta A, Brosh RM Jr. Holding All the cards-how Fanconi anemia proteins deal with replication stress and preserve genomic stability. Genes (Basel) 2019; 10: 170.

6. Alter B. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D (eds). Nathan's and Oski's Hematology of Infancy and Childhood (6th ed). WB Saunders: Philadelphia, 2003: 281-365.

7. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101: 1249-1256.

8. Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: An International Fanconi Anemia Registry Study. Am J Med Genet 1997; 68: 58-61.

9. Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007; 92: 2624-2631.

10. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet 2015; 85: 8.7.1-8.7.17.

11. Francies FZ, Wainwright R, Poole J, et al. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei. DNA Repair (Amst) 2018; 61: 17-24.

12. Auerbach AD.Diagnosis of fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet 2003; 37: 8.7.1-8.7.15.

13. Kuskonmaz B, Unal S, Bayhan T, et al. Successful outcome with fludarabine-based conditioning regimen for hematopoietic stem cell transplantation from related donor in Fanconi anemia: A single center experience from Turkey. Pediatr Blood Cancer 2016; 63: 695-700.

14. Bessler M, Mason PJ, Link DC, Wilson DB. Inherited bone marrow failure syndromes. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE (eds). Nathan's and Oski's Hematology of Infancy and Childhood (7th ed). WB Saunders: Philadelphia, 2009: 307-395.

15. Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: A literature review. Blood Rev 2019; 37: 100589.

16. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001; 107: 744-754.

17. Alter BP. Fanconi anemia and the development of leukemia. Best Pract Res Clin Haematol 2014; 27: 214-221.

18. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood 2003; 101: 2072.

19. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003; 101: 822-826